Researchers Validate ArcherDx Targeted Sequencing Approach for Sarcoma Gene Fusions

NEW YORK (GenomeWeb) – Researchers at Leiden University Medical Center have used a genotyping assay and next-generation sequencing workflow developed by ArcherDx to detect gene fusions in sarcoma patients.

The team believes that the assay could eventually be developed into a multiplex diagnostic tool to diagnose rare forms of sarcoma.

Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Be the first to comment

Leave a Reply

Your email address will not be published.